Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
Facebook page “TCP Group” impersonates “T.C. Pharmaceutical Industries Co., Ltd.” : Unlicensed securities and derivatives business (Disclosure Date : 05/08/2024)
Type of securities : Common share | Effective Date : 19/10/2021 | Close Selling Date : 26/10/2021
of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit
Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27
work constructively with the company to remove the impediment. A recent example of this type of engagement had to do with the mix of skill sets on a pharmaceutical company’s board. Several years before
Constructions (2) Registration of 100 drugs formulas (54 formulas for human medicine and 46 formulas for animals) owned by the seller (3) Registration of special drug formulas, consisting of 12 formulas including
the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or
involves severely illegal business. For example, human trafficking, drug smuggling or money laundering etc. Moreover, the issuer must not act in violation or non-compliance with the law, which may cause
represents more than fifty percent of the total number of the voting rights of any company under (a). (c) any company holding shares at any level in the sequence of ownership, starting from any company under